Menu

Recent Interviews

Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)

info@rohstoff.de

+49 621 490 817 0

Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."


Steve Cope, President, CEO and Director, Silver Viper

Steve Cope
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)

info@silverviperminerals.com

+1-604-687-8566

Interview with Silver Viper: Future price drivers and takeover fantasy


03. December 2020 | 12:04 CET

Aurelius, Berkshire Hathaway, SolGold: Invest like Warren Buffett

  • Investments
Photo credits: SolGold PLC

Conglomerates and holding companies are the general stores of the stock exchange: There is something for everyone, but these companies usually do not have a sharp profile. As a result, the market often does not recognize the intrinsic value of these companies and trades the shares at a discount. This discounted trading happened over many months with Aurelius. The investment Company has set its sights on medium-sized companies and focuses on companies with growth potential. After the purchase, Aurelius intervenes in the business and develops an individual concept for each of its subsidiaries. Once the holdings have grown and are ready for an exit, Aurelius sets about selling them - and often generates substantial profits.

time to read: 3 minutes by Nico Popp


 

Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author


Why Aurelius has further potential

In the course of the crisis, however, the business with corporate investments has ebbed. In particular, investors who were looking for a quick windfall have left Aurelius. This trend is also supported by the fact that Aurelius today is less of an agile grasshopper and more of a classic long-term investment Company. Many shareholders have to get used to this. But there are also opportunities, especially in the long-term orientation: the more sustainable a development at subsidiaries, the higher the price that can be achieved on the market. Another argument in favor of Aurelius is that the management has already proven that it can handle a wide range of challenges and achieve good results for shareholders.

The Aurelius share took off on the stock market last month and rose by a whopping 65%. On a one-year horizon, however, the Company still has a loss of 46%. From a technical chart point of view, however, the recent rise was a liberating blow and paved the way towards EUR 25 in the medium term. Investors should not overestimate the recent consolidation. Nevertheless, Aurelius remains speculative: if setbacks occur in the course of the pandemic, lucrative exits could move further into the distance. Conversely, however, the opportunity for promising long-term acquisitions also increases.

Berkshire Hathaway now also makes tech

The crisis is also regarded as a trendsetting market phase for Warren Buffett's Berkshire Hathaway, probably the world's best-known investment Company. In the past, the investment legend was able to conclude some very successful long-term deals during crises. Berkshire Hathaway is currently heavily involved in the insurance business, but also has holdings in Coca-Cola and American Express. The fact that Berkshire Hathaway definitely has a future and can even break new ground was demonstrated by the most recent investment in Cloudflare, a cloud provider in which Berkshire Hathaway has been invested since its IPO. Warren Buffett is not considered a tech investor, but the signature of his potential successors is already visible in this investment.

Berkshire Hathaway's stock has been rising like clockwork for years. The slump of the first quarter has now been made up for. Although the Company has cancelled the dividend, which is essential for many investors, this only shows where the focus of the team around Buffett currently lies: On new investments. The share remains a solid choice for all investors with a long-term perspective and also gives the impression of being well-positioned for the future.

SolGold: Billion-dollar Company with potential

Less of a general store, but still a jack-of-all-trades is the British gold company SolGold. The Company was one of the first to secure gold properties in Ecuador. In the meantime, a considerable number of projects have come together, and SolGold is valued at the stock exchange at CAD 1.3 billion. What makes SolGold unique is that the Company carries out work on almost all properties. While other companies in the exploration sector often have a large number of brownfields, investors can expect a continuous news flow from SolGold. There is a reason for this: if the Company brings several projects into production, synergy effects could arise.

SolGold shareholders wait for February

SolGold is currently working on the feasibility study for its Alpala project. Due to limited access to the property and capacity constraints in laboratories in Chile, management has used the time to further optimize the potential mine design and production plans. More details of the project should be available to the market by early February. SolGold already describes its Alpala project as extremely promising and expects profitable business with copper in addition to the extraction of the precious metal gold. The share has recently shown excellent relative strength in a more challenging environment for precious metals. In the long term, the Company's decisive action during the Corona Crisis could pay off.


Author

Nico Popp

At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. April 2021 | 09:45 CET | by Stefan Feulner

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

Read

20. April 2021 | 07:10 CET | by Carsten Mainitz

BioNTech, SunMirror, Steinhoff - Great News!

  • Investments

Shortly before the finish line, the going gets tough again. Many athletes and those who have to really "bite" in the last few meters before a deadline are probably familiar with this feeling. Everyday life in the Corona pandemic is also becoming more exhausting. Now, with BioNTech's announcement that it will double weekly vaccine dose deliveries to around 5.1 million units from the end of May, there may be a breakthrough in achieving herd immunity in Germany in the next few months. It is not only good news for the Company's shareholders but everyone. Below we present two other companies whose shareholders should be very pleased. Let us surprise you!

Read

15. April 2021 | 07:15 CET | by Stefan Feulner

Alibaba, The Place Holdings, CureVac - Great opportunities lie here!

  • Investments

The German vaccination disaster is going into the next round. After the AstraZeneca vaccine's back and forth and the question of whether only younger people, older people or no one should be vaccinated with the vaccine, the American vaccine manufacturer Johnson & Johnson is now experiencing delivery stoppages. The return to "normality" once again seems to be a long way off. Another question to ask yourself. What will future life in the new normal look like in the hard-pressed inner cities?

Read